News | April 01, 2025
Shin-Etsu Chemical to invest in pharmaceutical cellulose business
L-HPC was independently developed by Shin-Etsu Chemical as a disintegrant for tablets
L-HPC was independently developed by Shin-Etsu Chemical as a disintegrant for tablets
With the new facility, the company underlines its commitment to meet the substantially growing demand for its MCC
The plant will have installed production capacity of 3,120 MT/month
Univar Solutions' pharmaceutical ingredients portfolio will be strengthened by the addition of a broad range of cellulose ethers and other excipient solutions
Sigachi's entry into the coatings market is strategically timed to capitalize on the industry's growth potential
_in_Mizushima,_Japan_256_384.jpg)
Contributing to lower risk of potentially carcinogenic nitrosamine impurities in pharmaceuticals
The agreement grants Brinter the distribution rights of GrowInk bioinks in many countries
Moist wound dressing for chronic wound treatment now available in Germany
The need for hot-melt extrusion (HME) polymers is expected to grow as the pharma industry moves to implement more continuous and sustainable processes.
Supports development and commercialization of complex oral drugs using sensitive molecules, including biologicals
Subscribe To Our Newsletter & Stay Updated
